28 /100
MEDIUM RISK
Score updated Jul 13, 2026

AGL — agilon health, inc. Dilution Risk Tracker

Track AGL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AGL — Get alerts when the score changes →

As of July 13, 2026, agilon health, inc. (AGL) has a DilutionWatch DilutionScore of 28/100, rated MEDIUM dilution risk. agilon health, inc. has a market capitalization of $1.54B, 16.68M shares outstanding, 13 institutional holders tracked. Key dilution vectors include approximately 58 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
36
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AGL.
🔔 Track AGL — Get forecast alerts →

💹 Market Data

Market Cap$1.54B
Shares Outstanding16.68M
Float9.83M
Cash$562.48M
Debt$30.02M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 56.2% shares (2026Q1 vs prior)
13 institutional holders · 165.77M shares
#1 MORGAN STANLEY 113.26M shares
#2 Rubicon Founders LLC 25.32M shares
#3 GOLDMAN SACHS GROUP INC 20.06M shares
+ 10 more holders Sign up free to view →

📉 Short Interest

Short Interest723.2K
Days to Cover1.9
% of Float7.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Apr 16, 2026
4 INSIDER TRANSACTION Apr 16, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for AGL Shareholders

agilon health, inc. (AGL) has a DilutionScore of 28/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for AGL shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for AGL in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for AGL alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track AGL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AGL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for AGL
📊 AGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AGL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.